Criteria
Checklist for Administration of t-PA (Tissue Plasminogen Activator) for
acute stroke
|
NO |
YES |
"Inclusion
Criteria – SHOULD BE ALL "YES |
| |
|
Clinical Diagnosis of
ischemic stroke causing a measurable deficit defined as impairment
of language, motor function, cognition, 0vision |
| |
|
Time of onset of stroke
well established to be less than 3 hours (180 minutes) |
| |
|
CT negative for
intracranial hemorrhage |
| |
|
Age greater or equal to 18
years |
| |
|
Documented discussion of
risks and benefits of treatment with patient and/or designated
decision-maker |
| |
|
Discussed with Neurology
and consensus exists for thrombolysis |
|
YES |
NO |
Exclusion Criteria --
SHOULD BE ALL "NO" |
| |
|
Only minor or rapidly
improving stroke symptoms |
| |
|
A profound stroke with
obtundation, fixed eye deviation and complete hemiplegia |
| |
|
Clinical presentation
consistent with subarachnoid hemorrhage even if CT normal |
| |
|
BP greater than 185 / 110
mmHg |
| |
|
Use of anticoagulants in
previous 48 hours and a prolonged PTT or an INR greater than 1.5 |
| |
|
Platelet count less than
100,000 |
| |
|
Active internal bleeding |
| |
|
Gastrointestinal or
urinary bleeding within 21 days |
| |
|
Major surgery within 14
days |
| |
|
Blood, serum or plasma
Blood Glucose less than 3 or greater than 22 mmol/L |
| |
|
Seizures within 6 hours of
onset of stroke |
| |
|
Myocardial infarction
within 3 weeks |
| |
|
Pregnant or lactating
women |
| |
|
Within 3 months of any
intracranial surgery, serious head trauma or previous stroke |
| |
|
History of intracranial
hemorrhage |
| |
|
Known arteriovenous
malformation or aneurysm |
| |
|
Arterial puncture at a
non-compressible site |
| |
|
Lumbar puncture within 7
days |
| |
|
Acute pericarditis |
Phase
II Orders (Stroke Thrombolytic Therapy)
| 1. |
Inclusion / Exclusion
criteria completed and signed |
|
2. |
Second IV access: saline
lock with saline flush in same arm. |
|
3 |
Cardiac monitor during
infusion of tPA |
|
4.
|
Total dose of tPA:
__________ mg over 1 minute as 10% bolus, followed immediately by
___________ mg IV continuous infusion over 60 minutes, for a total
of _____________ mgs
DOSE CALCULATIONS:
Choose the smallest of the following:
a] Patient’s weight in
kg _________x 0.9 mg/kg _________mg.
OR
b] Maximum dose of 90
mgs (Maximum bolus of 9 mgs
Total dose __________ mg
|
|
5. |
Neurovitals and blood
pressure q 15 min x 1 hour after start of infusion,
then q 30 min x 2 hours
then q 1 h x 1 6 hours
then q 2 h x 24 hours
if stable q 6 h x 48
hours
then q12h
Temperature q 2 hr x 24
hours then as per clinical unit routines |
|
6. |
NPO except for meds for
24 hours then see Admission Orders. |
|
7. |
No heparin, warfarin ,
aspirin, ticlopidine or clopidogrel or other antiplatelet or
anticoagulant durgs or NSAIDs for 24 hours |
|
8.
|
Bleeding precautions:
check puncture sites for bleeding or hematomas.
Apply digital pressure
dressings to active compressible bleeding sites.
Evaluate urine, stool,
emesis or other secretions for blood. |
|
9.
|
Notify most responsible
physician immediately if evidence of bleeding, neurological
deterioration and/or
vital signs outside:
· Systolic blood
pressure greater than 185 or less than 110 mm Hg
· Diastolic blood
pressure greater than 95 or less than 60 mmHg for 2 or more readings
taken more than 5-10 minutes apart
· Pulse less than 50 /
min
· Respiration Rates
greater than 24
· Temperature greater
than38° C |
|
10. |
Monitor intake / output
x 48 hours and reassess |
|
11. |
Avoid intramuscular
injections, blood draws, catheterizations or other invasive line /
procedures for 24 hours after thrombolysis treatment. |
|
12. |
Bladder care:If
incontinent: in-out catheterization for residual volume, send for
R&M.
Notify most responsible
physician if volume more than 200 mL.
If patient does not void
within next 8 hours: In-out catheterization for volume.
Send for R&M,
culture and sensitivity. Catheterize q6h prn.
Notify most responsible
physician if volume less than 200 mL over 8 hours |
|
13. |
Activity: bathroom
privileges |
HAMILTON
HOSPITALSr-tPA DOSING CHART FOR ACUTE ISCHEMIC STROKE
| Weight in kg
(lbs) |
Total Dose |
Vial Size |
Amount removed
from vial |
10% bolus |
90% remaining
dose |
| 41 (90) |
37 |
50 |
13 |
4 |
33 |
| 42 (93) |
38 |
50 |
12 |
4 |
34 |
| 43 (95) |
39 |
50 |
11 |
4 |
35 |
| 44 (97) |
40 |
50 |
10 |
4 |
36 |
| 45 (99) |
41 |
50 |
9 |
4 |
37 |
| 46 (101) |
41 |
50 |
9 |
4 |
37 |
| 47 (103) |
42 |
50 |
8 |
4 |
38 |
| 48 (106) |
43 |
50 |
7 |
4 |
39 |
| 49 (108) |
44 |
50 |
6 |
4 |
40 |
| 50 (110) |
45 |
50 |
5 |
5 |
40 |
| 51 (112) |
46 |
50 |
4 |
5 |
41 |
| 52 (114) |
47 |
50 |
3 |
5 |
42 |
| 53 (117) |
48 |
50 |
2 |
5 |
43 |
| 54 (119) |
49 |
50 |
1 |
5 |
44 |
| 55 (121) |
50 |
50 |
0 |
5 |
45 |
| 56 (123) |
50 |
50 |
0 |
5 |
45 |
| 57 (125) |
51 |
100 |
49 |
5 |
46 |
| 58 (128) |
52 |
100 |
48 |
5 |
47 |
| 59 (130) |
53 |
100 |
47 |
5 |
48 |
| 60 (132) |
54 |
100 |
46 |
5 |
49 |
| 61 (134) |
55 |
100 |
45 |
5 |
50 |
| 62 (136) |
56 |
100 |
44 |
6 |
50 |
| 63 (139) |
57 |
100 |
43 |
6 |
51 |
| 64 (141) |
58 |
100 |
42 |
6 |
52 |
| 65 (143) |
59 |
100 |
41 |
6 |
53 |
| 66 (145) |
59 |
100 |
41 |
6 |
53 |
| 67 (147) |
60 |
100 |
40 |
6 |
54 |
| 68 (150) |
61 |
100 |
39 |
6 |
55 |
| 69 (152) |
62 |
100 |
38 |
6 |
56 |
| 70 (154) |
63 |
100 |
37 |
6 |
57 |
| 71 (156) |
64 |
100 |
36 |
6 |
58 |
| 72 (158) |
65 |
100 |
35 |
6 |
59 |
| 73 (161) |
66 |
100 |
34 |
7 |
59 |
| 74 (163) |
67 |
100 |
33 |
7 |
60 |
| 75 (165) |
68 |
100 |
32 |
7 |
61 |
| 76 (167) |
68 |
100 |
32 |
7 |
61 |
| 77 (169) |
69 |
100 |
31 |
7 |
62 |
| 78 (172) |
70 |
100 |
30 |
7 |
63 |
| 79 (174) |
71 |
100 |
29 |
7 |
64 |
| 80 (176) |
72 |
100 |
28 |
7 |
65 |
| 81 (178) |
73 |
100 |
27 |
7 |
66 |
| 82 (180) |
74 |
100 |
26 |
7 |
67 |
| 83 (183) |
75 |
100 |
25 |
7 |
68 |
| 84 (185) |
76 |
100 |
24 |
8 |
68 |
| 85 (187) |
77 |
100 |
23 |
8 |
69 |
| 86 (189) |
77 |
100 |
23 |
8 |
69 |
| 87 (191) |
78 |
100 |
22 |
8 |
70 |
| 88 (194) |
79 |
100 |
21 |
8 |
71 |
| 89 (196) |
80 |
100 |
20 |
8 |
72 |
| 90 (198) |
81 |
100 |
19 |
8 |
73 |
| 91 (200) |
82 |
100 |
18 |
8 |
74 |
| 92 (202) |
83 |
100 |
17 |
8 |
75 |
| 93 (205) |
84 |
100 |
16 |
8 |
76 |
| 94 (207) |
85 |
100 |
15 |
8 |
77 |
| 95 (209) |
86 |
100 |
14 |
9 |
77 |
| 96 (211) |
86 |
100 |
14 |
9 |
77 |
| 97 (213) |
87 |
100 |
13 |
9 |
78 |
| 98 (216) |
88 |
100 |
12 |
9 |
79 |
| 99 (218) |
89 |
100 |
11 |
9 |
80 |
| 100 (220) |
90 |
100 |
10 |
9 |
81 |
| 100 + (220 +) |
90 |
100 |
10 |
9 |
81 |
GIVING
r-tPA for Acute Ischemic Stroke
1. Mix 100mg of r-tPA with
diluent (not IV solution).
2. Check STROKE medication
chart for exact total amount to be given.
3. Use syringe and withdraw
amount to be discarded prior to hanging of the bottle (bottle should
now only contain exact amount to be given.)
4. Hang bottle using IVAC
tubing.
5. Carefully prime tubing and
set up IVAC machine.
Use of IVAC
5.1. BOLUS:
· Clear - volume infused.
· Set - volume to be
infused @ bolus dose specified per weight
(maximum bolus dose is 9mg—maximum dose is 90 mg)
· Set - IVAC rate @ 270 mL/hr.
· Turn IVAC on - will
infuse @ 9 mL in 2 minutes.
5.2. NEXT 60 MINUTES
· Clear - volume infused.
· Set - volume to be
infused @ amount specified on chart.
· Set - rate @ the same
amount to be infused.
· Turn IVAC on - will alarm
when tPA bottle empty
(remember that part of the amount of the r-tPA is still in the tubing)
· Replace r-tPA bottle with
250 cc of Normal Saline.
· Turn IVAC back on - will
alarm when total amount is absorbed
(now all the r-tPA in the tubing is absorbed as well)
STROKE
- ADMISSION ORDERS POST-THROMBOLYSIS (Phase III)
| 1. |
BRP first 24 hours then
as tolerated |
| 2. |
Initiate DVT prophylaxis
24 hours after thrombolysis
|
| 3. |
Initiate antiplatelet or
anticoagulant stroke prophylaxis 24 hours after thrombolysis
|
| 4. |
Consult the following:
(cross out those not required)
Physiotherapy; Social
Work
Occupational
Therapy Speech/Language Pathologist
Registered Dietician
Neurology |
| 5. |
Bladder care:
If incontinent: in-out
catheterization for residual volume, send for R&M. Notify most
responsible physician if volume more than 200 mL.
If patient does not void
within next 8 hours: In-out catheterization for volume. Send for
R&M, culture and sensitivity. Catheterize q6h prn.
Notify most responsible
physician if volume less than 200 mL over 8 hours |
| 6. |
Bowel Care: Docusate
sodium 100 mg bid.
If no BM in 2 days, give
Magnesium Hydroxide (Milk of Magnesium) 30 mL po qhs.
If no BM on day 3, give
Bisacodyl suppository (Dulcolax) 10 mg per rectum, followed by
sodium phosphate (Fleet) enema if needed.
Repeat protocol if
needed. |